Nordhealth AS (OSL:NORDH)
Norway · Delayed Price · Currency is NOK 23.60
0.00 (0.00%)
Aug 4, 2026, 4:25 PM CET
Nordhealth AS Ratios and Metrics
Market cap in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,860 | 2,923 | 3,578 | 1,967 | 1,784 | 3,214 | |
Market Cap Growth | -39.09% | -18.32% | 81.86% | 10.30% | -44.50% | - |
Enterprise Value | 1,692 | 2,749 | 3,345 | 1,718 | 1,373 | 2,486 |
Last Close Price | 23.60 | 37.08 | 44.62 | 24.58 | 22.24 | 40.18 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 44.38 | 150.51 | 52.81 | 52.81 | 94.36 |
PS Ratio | 3.20 | 4.86 | 6.61 | 4.75 | 5.48 | 15.79 |
PB Ratio | 2.84 | 4.01 | 4.10 | 2.11 | 1.73 | 2.80 |
P/TBV Ratio | 141.66 | 222.58 | 188.82 | 92.99 | 58.47 | 48.06 |
P/FCF Ratio | - | - | - | - | - | 146.36 |
P/OCF Ratio | - | 343.43 | 163.38 | - | - | 57.58 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.91 | 4.57 | 6.18 | 4.15 | 4.22 | 12.21 |
EV/EBITDA Ratio | - | - | 91.42 | - | - | - |
EV/FCF Ratio | - | - | - | - | - | 113.20 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | - | 0 | 0 | 0 | 0 | 0.00 |
Debt / FCF Ratio | - | - | - | - | - | 0.02 |
Net Debt / Equity Ratio | -0.24 | -0.24 | -0.27 | -0.27 | -0.40 | -0.63 |
Net Debt / EBITDA Ratio | 12.40 | 12.40 | -6.35 | 17.77 | 6.56 | 327.11 |
Net Debt / FCF Ratio | 3.36 | 3.36 | 6.19 | 2.03 | 2.94 | -33.16 |
Asset Turnover | 0.66 | 0.66 | 0.52 | 0.36 | 0.26 | 0.29 |
Quick Ratio | 2.08 | 2.08 | 2.87 | 3.05 | 2.74 | 7.64 |
Current Ratio | 2.21 | 2.21 | 2.99 | 3.14 | 2.85 | 7.71 |
Return on Equity (ROE) | -18.76% | -18.76% | -9.81% | -12.27% | -13.38% | -7.92% |
Return on Assets (ROA) | -16.65% | -16.65% | -10.21% | -11.34% | -12.35% | -6.58% |
Return on Invested Capital (ROIC) | -27.45% | -25.51% | -15.59% | -19.54% | -29.24% | -20.15% |
Return on Capital Employed (ROCE) | -18.41% | -18.41% | -9.86% | -12.53% | -13.71% | -7.18% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
FCF Yield | - | - | - | - | - | 0.68% |
Dividend Yield | - | 0.00% | 0.00% | 0.00% | 0.00% | 1.16% |
Payout Ratio | - | 0.00% | 0.00% | 0.00% | 0.00% | -78.86% |
Buyback Yield / Dilution | - | 1.72% | -0.10% | 0.10% | -0.24% | - |
Total Shareholder Return | - | 1.72% | -0.10% | 0.10% | -0.24% | 1.16% |